Vor Historical Financial Ratios

VOR Stock  USD 0.98  0.0007  0.07%   
Vor Biopharma is promptly reporting on over 88 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0, PTB Ratio of 0.95 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Vor Biopharma financial condition quickly.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vor Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Vor Stock, please use our How to Invest in Vor Biopharma guide.

About Vor Financial Ratios Analysis

Vor BiopharmaFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Vor Biopharma investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Vor financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Vor Biopharma history.

Vor Biopharma Financial Ratios Chart

At this time, Vor Biopharma's Payables Turnover is relatively stable compared to the past year. As of 12/13/2024, Debt To Equity is likely to grow to 0.25, while Book Value Per Share is likely to drop 1.96.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Income Quality

An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.
Most ratios from Vor Biopharma's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Vor Biopharma current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vor Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Vor Stock, please use our How to Invest in Vor Biopharma guide.At this time, Vor Biopharma's Payables Turnover is relatively stable compared to the past year. As of 12/13/2024, Debt To Equity is likely to grow to 0.25, while Book Value Per Share is likely to drop 1.96.

Vor Biopharma fundamentals Correlations

0.23-0.05-0.02-0.081.0-0.03-0.780.080.010.08-0.26-0.58-0.03-0.210.750.61-0.81-0.25-0.480.54-0.19-0.040.620.210.23
0.23-0.59-0.95-0.770.23-0.96-0.66-0.90.820.980.77-0.790.150.8-0.40.86-0.590.780.640.860.8-0.530.820.991.0
-0.05-0.590.750.95-0.050.720.580.8-0.91-0.52-0.790.73-0.76-0.80.5-0.380.54-0.79-0.71-0.67-0.81.0-0.4-0.56-0.59
-0.02-0.950.750.88-0.021.00.570.99-0.93-0.94-0.920.76-0.32-0.930.62-0.70.5-0.93-0.83-0.81-0.940.71-0.68-0.93-0.95
-0.08-0.770.950.88-0.080.860.640.89-0.94-0.71-0.880.82-0.7-0.90.55-0.560.59-0.89-0.79-0.79-0.90.93-0.61-0.76-0.77
1.00.23-0.05-0.02-0.08-0.03-0.780.080.010.08-0.26-0.58-0.03-0.210.750.61-0.81-0.25-0.480.54-0.19-0.040.620.210.23
-0.03-0.960.721.00.86-0.030.580.98-0.92-0.95-0.910.76-0.26-0.920.6-0.720.5-0.91-0.82-0.82-0.930.67-0.7-0.94-0.96
-0.78-0.660.580.570.64-0.780.580.51-0.55-0.51-0.390.96-0.27-0.44-0.18-0.820.99-0.4-0.16-0.93-0.460.56-0.88-0.62-0.66
0.08-0.90.80.990.890.080.980.51-0.95-0.9-0.960.72-0.35-0.960.7-0.60.43-0.96-0.89-0.76-0.960.75-0.59-0.87-0.9
0.010.82-0.91-0.93-0.940.01-0.92-0.55-0.950.80.88-0.740.540.89-0.590.54-0.480.880.80.740.89-0.880.510.790.82
0.080.98-0.52-0.94-0.710.08-0.95-0.51-0.90.80.78-0.670.110.79-0.490.79-0.430.790.680.760.8-0.460.730.980.98
-0.260.77-0.79-0.92-0.88-0.26-0.91-0.39-0.960.880.78-0.630.421.0-0.830.45-0.321.00.970.661.0-0.760.490.750.77
-0.58-0.790.730.760.82-0.580.760.960.72-0.74-0.67-0.63-0.37-0.670.1-0.820.93-0.64-0.43-0.99-0.690.71-0.89-0.75-0.79
-0.030.15-0.76-0.32-0.7-0.03-0.26-0.27-0.350.540.110.42-0.370.41-0.290.03-0.250.420.40.260.41-0.790.110.190.15
-0.210.8-0.8-0.93-0.9-0.21-0.92-0.44-0.960.890.791.0-0.670.41-0.80.49-0.371.00.960.711.0-0.770.540.780.8
0.75-0.40.50.620.550.750.6-0.180.7-0.59-0.49-0.830.1-0.29-0.80.04-0.24-0.82-0.94-0.15-0.790.490.01-0.4-0.4
0.610.86-0.38-0.7-0.560.61-0.72-0.82-0.60.540.790.45-0.820.030.490.04-0.780.470.260.880.51-0.330.940.860.86
-0.81-0.590.540.50.59-0.810.50.990.43-0.48-0.43-0.320.93-0.25-0.37-0.24-0.78-0.34-0.1-0.9-0.390.52-0.85-0.54-0.59
-0.250.78-0.79-0.93-0.89-0.25-0.91-0.4-0.960.880.791.0-0.640.421.0-0.820.47-0.340.970.681.0-0.760.510.760.78
-0.480.64-0.71-0.83-0.79-0.48-0.82-0.16-0.890.80.680.97-0.430.40.96-0.940.26-0.10.970.470.95-0.690.290.630.64
0.540.86-0.67-0.81-0.790.54-0.82-0.93-0.760.740.760.66-0.990.260.71-0.150.88-0.90.680.470.72-0.640.930.830.86
-0.190.8-0.8-0.94-0.9-0.19-0.93-0.46-0.960.890.81.0-0.690.411.0-0.790.51-0.391.00.950.72-0.770.550.780.8
-0.04-0.531.00.710.93-0.040.670.560.75-0.88-0.46-0.760.71-0.79-0.770.49-0.330.52-0.76-0.69-0.64-0.77-0.37-0.5-0.53
0.620.82-0.4-0.68-0.610.62-0.7-0.88-0.590.510.730.49-0.890.110.540.010.94-0.850.510.290.930.55-0.370.820.82
0.210.99-0.56-0.93-0.760.21-0.94-0.62-0.870.790.980.75-0.750.190.78-0.40.86-0.540.760.630.830.78-0.50.820.99
0.231.0-0.59-0.95-0.770.23-0.96-0.66-0.90.820.980.77-0.790.150.8-0.40.86-0.590.780.640.860.8-0.530.820.99
Click cells to compare fundamentals

Vor Biopharma Account Relationship Matchups

Vor Biopharma fundamentals Accounts

201920202021202220232024 (projected)
Ptb Ratio182.228.842.01.051.00.95
Book Value Per Share0.211.35.826.342.241.96
Free Cash Flow Yield(0.007617)(0.0291)(0.17)(0.36)(0.67)(0.64)
Operating Cash Flow Per Share(0.27)(0.98)(1.86)(2.15)(1.49)(1.57)
Pb Ratio182.228.842.01.051.00.95
Free Cash Flow Per Share(0.29)(1.09)(1.96)(2.37)(1.51)(1.58)
Roic(1.44)(0.66)(0.29)(0.32)(0.68)(0.71)
Net Income Per Share(0.31)(1.17)(1.85)(2.29)(1.75)(1.84)
Payables Turnover0.130.592.885.064.284.5
Cash Per Share0.171.315.585.822.042.01
Pocfratio(141.25)(38.36)(6.25)(3.09)(1.51)(1.58)
Pfcf Ratio(131.28)(34.42)(5.91)(2.81)(1.49)(1.57)
Days Payables Outstanding2.8K621.32126.772.1985.1980.93
Income Quality0.910.841.00.920.850.69
Roe(1.5)(0.9)(0.32)(0.36)(0.78)(0.82)
Ev To Operating Cash Flow(140.59)(37.53)(4.78)(2.87)(1.55)(1.63)
Pe Ratio(121.6)(32.13)(6.28)(2.9)(1.28)(1.35)
Return On Tangible Assets(1.16)(0.57)(0.28)(0.3)(0.59)(0.62)
Ev To Free Cash Flow(130.67)(33.67)(4.52)(2.61)(1.53)(1.61)
Earnings Yield(0.008223)(0.0311)(0.16)(0.35)(0.78)(0.74)
Net Debt To E B I T D A0.640.721.510.21(0.0376)(0.0357)
Current Ratio3.454.8121.1218.069.047.54
Tangible Book Value Per Share0.211.35.826.342.241.96
Graham Number1.25.8415.5618.099.417.27
Shareholders Equity Per Share0.211.35.826.342.241.96
Graham Net Net0.120.564.874.591.341.37
Interest Debt Per Share0.01640.490.480.980.530.46
Enterprise Value Over E B I T D A(136.21)(32.47)(4.89)(2.69)(1.36)(1.43)
Price Earnings Ratio(121.6)(32.13)(6.28)(2.9)(1.28)(1.35)
Price Book Value Ratio182.228.842.01.051.00.95
Days Of Payables Outstanding2.8K621.32126.772.1985.1980.93
Price To Operating Cash Flows Ratio(141.25)(38.36)(6.25)(3.09)(1.51)(1.58)
Price To Free Cash Flows Ratio(131.28)(34.42)(5.91)(2.81)(1.49)(1.57)

Pair Trading with Vor Biopharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vor Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vor Biopharma will appreciate offsetting losses from the drop in the long position's value.

Moving against Vor Stock

  0.66GNFT GenfitPairCorr
  0.63IMAB I MabPairCorr
  0.55FLGC Flora Growth Corp Buyout TrendPairCorr
The ability to find closely correlated positions to Vor Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vor Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vor Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vor Biopharma to buy it.
The correlation of Vor Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vor Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vor Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vor Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Vor Stock Analysis

When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.